Table 1.

Baseline patient characteristic: gene expression cohort

Variable	M0 n (%)	HEP n (%)	PER n (%)	p-value
Patients	6	6	6
Medium age (y)	71	69	71	0.72
Sex
Female	5 (83.0)	4 (47.0)	4 (52.5)	0.75
Male	1 (17.0)	2 (33.3)	2 (33.3)
Location of PT
Right colon	2 (33.3)	2 (33.3)	4 (66.7)	0.40
Left colon	4 (66.7)	4 (66.7)	2 (33.3)
UICC				>  0.9
I	0 (0.0)	0 (0.0)	0 (0.0)
II	0 (0.0)	0 (0.0)	0 (0.0)
III	6 (100.0)	1 (0.17)	0 (0.0)
IV	0 (0.0)	5 (99.82)	6 (100.0)
Grading
Low grade	3 (50.0)	3 (50.0)	3 (50.0)	0.99
High grade	3 (56.9)	3 (50.0)	3 (50.0)
Time of liver metastases
Synchron	n.a.	5 (83.0)	n.a.	n.a.
Metachron	n.a.	1 (17.0)	n.a.
Chemotherpy
Yes	6 (100.0)	6 (100.0)	6 (100.0)	>  0.9
No	0 (0.0)	0 (0.0)	0 (0.0)

UICC union for international cancer control